1 / 7

Liquid Biopsy Market 2020

The Global Liquid Biopsy Market is expected to register 28.0% CAGR and is projected to reach USD 17,372.28 million by 2022.

aditi3019
Download Presentation

Liquid Biopsy Market 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Liquid Biopsy Market 2020-2022 Industry Survey, Growth, Competitive Landscapeand Forecasts to 2022 PREPARED BY Market Research Future (Part of Wantstats Research & Media Pvt. Ltd.)

  2. Liquid Biopsy Market 2020-2022 Liquid BiopsyMarket Highlights The Global Liquid Biopsy Market is expected to register 28.0% CAGR and is projected to reach USD 17,372.28 million by 2022. A liquid biopsy is a largely non-invasive, sampling and analysis of liquid state biological tissue for diagnostic and monitoring diseases such as cancer. Liquid biopsy is the direct clinical application of two advances in medical science, namely, human genome sequencing and rising sensitivity of detecting techniques and assays. Liquid biopsy capitalizes on the qualitative and quantitative difference between different biomarkers such as cell-free DNA, circulating tumor cells (CTCs), cell-free RNA (cfRNA) fragments, methylated ctDNA, and miRNA in a patient's blood. Although some of these fragments are released even during other conditions such as trauma, there exists a quantitative difference in the form of their composition and concentration as well as their degree of fragmentation. www.marketresearchfuture.com

  3. Liquid Biopsy Market 2020-2022 Liquid Biopsy Market Regional Analysis • The global liquid biopsy in the healthcare market, on the basis of region, is segmented into North America, Europe, Asia-Pacific, and Middle East & Africa. • North America accounted for the largest market share of 37.95% in 2016, and Asia-Pacific is the fastest-growing market. The technology of liquid biopsy was developed in the US and several European countries, which is reflected in the dominance of these two regions in their respective market share. The European market is projected to grow at the highest CAGR of 28.5%. The venture capital available to life sciences companies has more than doubled from 2001 to 2010. In Europe, the UK accounts for almost 20% of all investments, and almost 20% of the UK venture capital was invested in the healthcare sector. Asia-Pacific is the fastest-growing market and is expected to grow at a CAGR of 29.7% during the forecasted period. Browse Complete Report with TOC @ https://www.marketresearchfuture.com/reports/liquid-biopsy-market-710 www.marketresearchfuture.com

  4. Liquid Biopsy Market 2020-2022 Liquid BiopsyMarket Segmental Analysis • The global liquid biopsy market has been segmented into biomarker types, application, samples, and end user.  • Based on biomarker types, the global market is segmented into circulating tumor cells (CTCS), circulating tumor DNA (CTDNA), extracellular vesicles (EVS), and others. • Based on application, the global market has been segmented into cancer, reproductive health, and others. • Based on sample, the global market is segmented into blood sample, urine sample, forensic, and other sample. • Based on end user, the global market is segmented into hospitals and laboratories, academic and research centers, and other end users. Advances in detection technologies such as digital PCR, advanced cell capture technology, and multi-panel detection were the other driving factors for the commercial application of the technology. www.marketresearchfuture.com

  5. Liquid Biopsy Market 2020-2022 Liquid BiopsyMarketKey Players • Guardant Health, Inc. (US) • Trovagene, Inc. (California) • RainDance Technologies, Inc. (US) • Scienceioscience Inc.(California) • Admera Health (US), • Biocept, Inc. KGaA (US), • Circulogene Theranostics (Alabama), • Inivata Ltd (UK), • SAGA Diagnostics AB (Sweden), • Exosome Diagnostics (Massachusetts). Avail Free Sample @ https://www.marketresearchfuture.com/sample_request/710 www.marketresearchfuture.com

  6. ABOUT US MARKET RESEARCH FUTURE At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. For more information kindly visit www.marketresearchfuture.com or contact us at info@marketresearchfuture.com Copyright © 2018 Market Research Future All Rights Reserved. This document contains highly confidential information and is the sole property of Market Research Future. No part of it may be circulated, copied, quoted, or otherwise reproduced without the written approval of Market Research Future. www.marketresearchfuture.com

  7. MARKET RESEARCH FUTURE THANK YOU sales@marketresearchfuture.com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) www.marketresearchfuture.com

More Related